Russian Experts : More Than 40,000 People Participated in Russian Vaccine Clinical Trials, Preliminary Results to be Released in October at the Earliest

The Russian Satellite News Agency reported on September 7 that the new coronavirus vaccine 'Sputnik-V' jointly developed by the Russian Gamaleya Center and the experts of the Direct Investment Foundation was registered in Russia on August 18. Criticism and doubts from the state and enterprises. To this end, Kirill Dmitriev, president of the Russian Direct Investment Foundation, decided to respond to the criticism and answer some of their questions.

How many people will participate in clinical trials of Russian vaccines?

Dmitriev answered, 'Russia started the post-registration trial on August 26. More than 40,000 people participated, even earlier than the Phase III clinical trial of 30,000 people participated in by AstraZeneca in the United States. 'Sputnik-V' vaccine clinical trials will be launched this month in Saudi Arabia, the UAE, the Philippines, India and Brazil. The preliminary results will be released from October to November 2020.